Japan, Jan. 16 -- TAKEDA PHARMACEUTICAL CO LTD has got intellectual property rights for 'ANTIBODY DRUG CONJUGATES.' Other related details are as follows:
Application Number: JP,2023-203963
Category (FI): A61K39/395@T,A61K39/395@U,A61K41/00,A61K47/68,A61P35/00,A61P37/04,A61P43/00,121,C07K16/28
Stage: Grant (IP right document published.)
Filing Date: Dec. 1, 2023
Publication Date: March 19, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
